跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Lamosiz 50
Approved
STANDARD
Lamosiz 50
XL Laboratories Pvt Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
572b4e44b293304f
Company
XL Laboratories Pvt Ltd
Type
Standard
Approval Details
Approval Id
572b4e44b293304f
Drug Approval Philippines Name
Lamosiz 50
Product Name
Lamosiz 50
Registration Number
DRP-3340-02
Brand Name
Lamosiz 50
Generic Name
Lamotrigine
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
XL Laboratories Pvt Ltd
Importer
Ambica International Corporation
Distributor
Arrow Pharma Life, Inc.
Issuance Date
27 March 2024
Expiry Date
21 October 2029
Pharmacologic Category
Anticonvulsant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
572b4e44b293304f
Type
Standard
Back to Philippines FDA Approvals
Lamosiz 50 - Philippines FDA Drug Approval Details